Longevity

October 27, 2017

Natural product-based therapy for ageing-associated diseases: A therapeutic mix encompassing Lucidone, Asprin, and Sulforaphane (LAS) isolated from Lindera erythrocarpa Makino, Meadowsweet, and Broccoli, respectively, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 28/October/2017, 12.10 am

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
October 25, 2017

Lifespan extension therapy: Ciglitazone, an anti-diabetic medication,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 11.20 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 24, 2017

Lifespan extension therapy: Tetrahydrocannabinolic acid [THCA], found abundantly in Hemp Cannabis Sativa, among others,  may increase life span via up-regulation of its target gene BubR1, 25/October/2017, 12.38 am

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and […]
October 23, 2017

Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Linalool, Gastrodin, Puerarin (LGP) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 23/October/2017, 11.58 pm

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]